Clinical Trials on VHL-Associated Renal Cell Carcinoma
Total 12792 results
-
CoImmuneTerminatedAdvanced Renal Cell CarcinomaUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedMetastatic Renal Cell CarcinomaUnited States
-
Beth Israel Deaconess Medical CenterUniversity of California, Los Angeles; Dana-Farber Cancer Institute; Wayne State... and other collaboratorsCompletedMetastatic Renal Cell CarcinomaUnited States
-
Oslo University HospitalCompletedRenal Cell Carcinoma | Urothelial Carcinoma | Renal Stone | Renal CystNorway
-
Ankara Yildirim Beyazıt UniversityCompleted
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedMetastatic Renal Cell CancerChina
-
Eli Lilly and CompanyCompletedMetastatic Renal Cell CancerUnited States, Canada
-
University Hospital TuebingenUnknownRenal Cell Cancer | Advanced Renal Cell Cancer
-
RenJi HospitalNot yet recruitingImmune Checkpoint Inhibitors | Clear-cell Metastatic Renal Cell Carcinoma | Cytoreductive Nephrectomy
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruiting
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellPoland, Australia, Japan, United States, Korea, Republic of, Taiwan, China, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Finland, France, Germany, Greece, Hungary, Ireland, Israel, Italy, Malaysia, Mexico, Netherlands, New Zealand, Romani... and more
-
Antisoma ResearchCompletedMetastatic Renal Cell Carcinoma | Metastatic Malignant MelanomaUnited Kingdom, New Zealand
-
Ludwig Institute for Cancer ResearchMemorial Sloan Kettering Cancer CenterCompletedKidney Cancer | Renal Cell Carcinoma | Renal Cancer | Kidney NeoplasmUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical SciencesCompletedMetastatic Renal Cell Cancer | Renal Cell CancerChina
-
HiberCell, Inc.CovanceTerminatedA Study of HC-7366 to Establish the Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Clear Cell Renal Cell Carcinoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Colo-rectal Cancer | Transitional Cell Carcinoma of the Bladder | Other Solid TumorsUnited States
-
Rambam Health Care CampusRoche Pharma AGUnknown
-
UroGen Pharma Ltd.RecruitingCarcinoma, Transitional Cell | Urothelial Carcinoma | Urothelial Cancer of Renal Pelvis | Urothelial Carcinoma Ureter | Urothelial Carcinoma Recurrent | Urothelial Carcinoma of the Renal Pelvis and Ureter | Urothelial Carcinoma Ureter Recurrent | Transitional Cell Carcinoma of Renal PelvisUnited States
-
University of California, San FranciscoProstate Cancer Foundation; Strata OncologyActive, not recruitingProstate Cancer | Advanced Renal Cell Carcinoma | Genitourinary Cancer | Advanced Urothelial CarcinomaUnited States
-
Yonsei UniversityRecruitingClear Renal Cell Cancer (< 7cm Size)Korea, Republic of
-
National Cancer Institute (NCI)CompletedKidney CancerUnited States
-
National Cancer Institute (NCI)TerminatedMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter | Recurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent... and other conditionsUnited States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.Not yet recruitingRenal Cell Carcinoma
-
Peloton Therapeutics, Inc., a subsidiary of Merck...Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Clear Cell Renal Cell Carcinoma | ccRCC | RCCUnited States
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingCarcinoma, Renal CellUnited States, Colombia, Canada, Australia, Finland, Japan, United Kingdom, Brazil, Chile, China, Croatia, Czechia, Denmark, France, Germany, Guatemala, Hungary, Ireland, Italy, Korea, Republic of, Malaysia, Mexico, Norway, Philippines, Polan... and more
-
Aravive, Inc.TerminatedClear Cell Renal Cell CarcinomaUnited States
-
Seoul National University HospitalPfizerCompletedRenal Cell Carcinoma | Nonclear Cell | Temsirolimus ResistanceKorea, Republic of
-
PROspective Renal Cancer Cohort FoundationBristol-Myers Squibb; Merck Sharp & Dohme LLC; Ipsen; Comprehensive Cancer Centre...RecruitingRenal Cell Carcinoma | Renal Cancer | Renal Cell Cancer MetastaticNetherlands
-
Wenxin XuRecruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerActive, not recruitingRenal Cell Carcinoma Stage IVUnited States
-
Abramson Cancer Center at Penn MedicineTerminatedRenal Cell Carcinoma | Renal Cell Carcinoma Stage IVUnited States
-
Incyte CorporationMerck Sharp & Dohme LLCActive, not recruitingRenal Cell Carcinoma (RCC)Canada, France, United States, Spain, United Kingdom, Italy, Taiwan, Australia, Norway, Korea, Republic of, Germany, Russian Federation, Japan, Brazil, Turkey, Ukraine, Hungary, New Zealand, Chile, Ireland
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Recurrent Melanoma | Stage IV Melanoma | Gastrinoma | Glucagonoma | Insulinoma | Metastatic Gastrointestinal Carcinoid Tumor | Pancreatic Polypeptide Tumor | Recurrent Gastrointestinal Carcinoid Tumor | Recurrent Islet Cell Carcinoma | Somatostatinoma | Stage... and other conditionsUnited States
-
TScan Therapeutics, Inc.Washington University School of MedicineWithdrawnRenal Clear Cell CarcinomaUnited States
-
Gregory DanielsRecruitingMelanoma Stage Iv | Renal Cell Carcinoma, MetastaticUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellUnited States
-
Indiana UniversityActive, not recruitingMelanoma; Renal Cell CarcinomaUnited States
-
PsiOxus Therapeutics LtdCompletedResectable Colon Cancer | Resectable Non-small Cell Lung Cancer | Resectable Bladder Cancer | Resectable Renal Cell CarcinomaSpain
-
Seoul National University HospitalTerminatedMetastatic Malignant Melanoma and Renal Cell CarcinomaKorea, Republic of
-
Novartis PharmaceuticalsCompletedAdvanced/ Metastatic Renal Cell CancerFrance, Spain, Germany, Taiwan, Netherlands, United States
-
M.D. Anderson Cancer CenterRecruitingRenal Medullary Carcinoma | CarcinomasUnited States
-
Radboud University Medical CenterNovo Nordisk A/SCompletedRenal Cell CancerNetherlands
-
Osel, Inc.City of Hope Comprehensive Cancer Center; Miyarisan Pharmaceutical Co., Ltd.RecruitingAdvanced or Metastatic Renal Cell CarcinomaUnited States
-
john eisenbreyNational Cancer Institute (NCI)RecruitingRenal Cell Carcinoma | Recurrent Renal Cell CarcinomaUnited States
-
IpsenRecruitingAdvanced or Metastatic Renal Cell CarcinomaBelgium
-
National Cancer Institute, NaplesRecruitingMetastatic Renal Cell Carcinoma | RCCItaly
-
Stanford UniversityNational Institutes of Health (NIH)Active, not recruitingKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell CarcinomaUnited States
-
Radboud University Medical CenterCompletedMetastatic Renal Cell Cancer | GISTNetherlands
-
University of Texas Southwestern Medical CenterRecruitingRenal Cell Carcinoma | Renal Tumor | Renal Tumor, BenignUnited States
-
The Netherlands Cancer InstitutePfizerRecruitingRenal Cell CarcinomaNetherlands